• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常白蛋白尿型糖尿病肾病患者的尿液代谢组学分析

Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney Disease.

作者信息

Feng Qian, Li Yuanmeng, Yang Yuwei, Feng Jiafu

机构信息

College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Department of Medical Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou, China.

出版信息

Front Physiol. 2020 Oct 6;11:578799. doi: 10.3389/fphys.2020.578799. eCollection 2020.

DOI:10.3389/fphys.2020.578799
PMID:33123032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7573362/
Abstract

OBJECTIVE

Diabetic kidney disease (DKD) leads to low high albuminuria and gradually progresses to very high albuminuria with kidney insufficiency. However, about 20-40% of DKD is normoalbuminuric DKD (NADKD), which has impaired kidney function but normal urine albumin. This study is to investigate the urine metabolomic profiles of patients with NADKD and albuminuria DKD (ADKD).

METHODS

In total, 95 patients were divided into a simple diabetes mellitus group (SDM group), an ADKD group, and a NADKD group. All subjects were analyzed for urine metabolites using non-targeted metabolomics based on ultra-performance liquid chromatography - tandem mass spectrometry.

RESULTS

The urine metabolomic profiles of the SDM group, NADKD group, and ADKD group were significantly different, and 65 different metabolites were identified among the three groups. Metabolic pathway analysis of these differential metabolites found that the top three significantly changed metabolic pathways were linoleic acid metabolism, citrate cycle, and, arginine and proline metabolism. There are 12 metabolites enriched in these three metabolic pathways. In detail, compared with those in the SDM group, the levels of γ-linolenic acid in the ADKD group were increased significantly, while the levels of succinic acid, -aconitic acid, citric acid, L-proline, L-erythro-4-hydroxyglutamate, -methylhydantoin, -carbamoylputrescine, spermidine, and 5-aminopentanoic acid were reduced significantly; compared with those in the NADKD group, the levels of linoleic acid, γ-linolenic acid, and L-malic acid in the ADKD group were increased significantly ( < 0.05), while the levels of L-proline, L-erythro-4-hydroxyglutamate, -carbamoylputrescine, and spermidine were significantly reduced ( < 0.05). However, there were no significant difference between the SDM group and NADKD group ( > 0.05).

CONCLUSION

The urine metabolomic profiles between the NADKD group and the ADKD group are significantly different. Specifically, these two groups have distinct levels of linoleic acid, γ-linolenic acid, L-malic acid, L-proline, L-erythro-4-hydroxyglutamate, -carbamoylputrescine, and spermidine.

摘要

目的

糖尿病肾病(DKD)会导致低白蛋白尿,并逐渐发展为伴有肾功能不全的高白蛋白尿。然而,约20%-40%的DKD为正常白蛋白尿性糖尿病肾病(NADKD),其肾功能受损但尿白蛋白正常。本研究旨在调查NADKD患者和白蛋白尿性糖尿病肾病(ADKD)患者的尿液代谢组学特征。

方法

总共95例患者被分为单纯糖尿病组(SDM组)、ADKD组和NADKD组。所有受试者均采用基于超高效液相色谱-串联质谱的非靶向代谢组学方法分析尿液代谢物。

结果

SDM组、NADKD组和ADKD组的尿液代谢组学特征存在显著差异,三组之间共鉴定出65种不同的代谢物。对这些差异代谢物的代谢途径分析发现,变化最显著的前三条代谢途径为亚油酸代谢、柠檬酸循环以及精氨酸和脯氨酸代谢。这三条代谢途径中有12种代谢物富集。具体而言,与SDM组相比,ADKD组中γ-亚麻酸水平显著升高,而琥珀酸、顺乌头酸、柠檬酸、L-脯氨酸、L-赤藓糖-4-羟基谷氨酸、N-甲基乙内酰脲、N-氨甲酰腐胺、亚精胺和5-氨基戊酸水平显著降低;与NADKD组相比,ADKD组中亚油酸、γ-亚麻酸和L-苹果酸水平显著升高(P<0.05),而L-脯氨酸、L-赤藓糖-4-羟基谷氨酸、N-氨甲酰腐胺和亚精胺水平显著降低(P<0.05)。然而,SDM组和NADKD组之间无显著差异(P>0.05)。

结论

NADKD组和ADKD组之间的尿液代谢组学特征存在显著差异。具体而言,这两组在亚油酸、γ-亚麻酸、L-苹果酸、L-脯氨酸、L-赤藓糖-4-羟基谷氨酸、N-氨甲酰腐胺和亚精胺水平上存在明显差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/4910abfa3f27/fphys-11-578799-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/fc7b68e676bc/fphys-11-578799-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/67ea487abdc8/fphys-11-578799-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/adc58a5edc4f/fphys-11-578799-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/41dfa27eeada/fphys-11-578799-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/4910abfa3f27/fphys-11-578799-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/fc7b68e676bc/fphys-11-578799-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/67ea487abdc8/fphys-11-578799-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/adc58a5edc4f/fphys-11-578799-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/41dfa27eeada/fphys-11-578799-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/7573362/4910abfa3f27/fphys-11-578799-g005.jpg

相似文献

1
Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney Disease.正常白蛋白尿型糖尿病肾病患者的尿液代谢组学分析
Front Physiol. 2020 Oct 6;11:578799. doi: 10.3389/fphys.2020.578799. eCollection 2020.
2
Normoalbuminuric diabetic kidney disease.正常白蛋白尿的糖尿病肾病。
Front Med. 2017 Sep;11(3):310-318. doi: 10.1007/s11684-017-0542-7. Epub 2017 Jul 18.
3
Clinical features of and risk factors for normoalbuminuric diabetic kidney disease in hospitalized patients with type 2 diabetes mellitus: a retrospective cross-sectional study.住院 2 型糖尿病患者正常白蛋白尿期糖尿病肾病的临床特征及危险因素:一项回顾性横断面研究。
BMC Endocr Disord. 2021 May 22;21(1):104. doi: 10.1186/s12902-021-00769-8.
4
Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.比较 2 型糖尿病患者中非白蛋白尿和白蛋白尿性糖尿病肾病:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2022 Jun 3;13:871272. doi: 10.3389/fendo.2022.871272. eCollection 2022.
5
[Further understanding and paying attention to normoalbuminuric diabetic kidney disease].[对正常白蛋白尿性糖尿病肾病的进一步认识与关注]
Zhonghua Yu Fang Yi Xue Za Zhi. 2023 Oct 6;57(10):1663-1673. doi: 10.3760/cma.j.cn112150-20230404-00256.
6
Re-understanding and focusing on normoalbuminuric diabetic kidney disease.重新认识并关注正常白蛋白尿的糖尿病肾脏疾病。
Front Endocrinol (Lausanne). 2022 Dec 2;13:1077929. doi: 10.3389/fendo.2022.1077929. eCollection 2022.
7
Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease.氨基酸代谢组学分析研究揭示了糖尿病肾病的独特诊断模型。
Amino Acids. 2023 Nov;55(11):1563-1572. doi: 10.1007/s00726-023-03330-0. Epub 2023 Sep 22.
8
Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.尿液代谢组学揭示了糖尿病肾病的生物标志物及潜在发病机制。
Int Urol Nephrol. 2023 Apr;55(4):1001-1013. doi: 10.1007/s11255-022-03326-x. Epub 2022 Oct 18.
9
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.糖尿病患者肾功能下降的代谢组学标志物:来自慢性肾功能不全队列(CRIC)研究的证据。
Am J Kidney Dis. 2020 Oct;76(4):511-520. doi: 10.1053/j.ajkd.2020.01.019. Epub 2020 May 5.
10
Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study).使用基于质谱的代谢组学发现糖尿病肾病的早期生物标志物(芬兰糖尿病肾病研究)。
Metabolomics. 2012 Feb;8(1):109-119. doi: 10.1007/s11306-011-0291-6. Epub 2011 Feb 24.

引用本文的文献

1
Serum metabolic profiling in diabetic kidney disease patients using ultra-high performance liquid chromatography-tandem mass spectrometry.使用超高效液相色谱-串联质谱法对糖尿病肾病患者进行血清代谢谱分析。
Diabetol Metab Syndr. 2025 Jun 7;17(1):197. doi: 10.1186/s13098-025-01780-y.
2
Progress and perspectives of metabolic biomarkers in blood sample for diabetic microvascular complications.糖尿病微血管并发症血液样本中代谢生物标志物的研究进展与展望
Metabolomics. 2025 Mar 31;21(2):47. doi: 10.1007/s11306-025-02245-z.
3
Metabolomic profiling of adenine-induced CKD: pathway interconnections and kidney injury.

本文引用的文献

1
Prevalence of comorbidities in patients with type-2 diabetes mellitus.2 型糖尿病患者的共病患病率。
Prim Care Diabetes. 2020 Oct;14(5):431-434. doi: 10.1016/j.pcd.2019.12.006. Epub 2020 Jan 2.
2
Association of Untargeted Urinary Metabolomics and Lung Cancer Risk Among Never-Smoking Women in China.中国从不吸烟女性人群中靶向代谢组学与肺癌风险的相关性研究
JAMA Netw Open. 2019 Sep 4;2(9):e1911970. doi: 10.1001/jamanetworkopen.2019.11970.
3
The prevalence of normoalbuminuria and renal impairment in type 2 diabetes mellitus
.
腺嘌呤诱导的慢性肾脏病的代谢组学分析:通路互连与肾损伤
Toxicol Res (Camb). 2025 Mar 24;14(2):tfaf035. doi: 10.1093/toxres/tfaf035. eCollection 2025 Apr.
4
Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3-5 not receiving dialysis.未接受透析的慢性肾脏病 3-5 期患者继发甲状旁腺功能亢进的代谢组学特征。
Front Endocrinol (Lausanne). 2024 Jul 4;15:1406690. doi: 10.3389/fendo.2024.1406690. eCollection 2024.
5
Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).代谢组学在糖尿病肾病中的研究进展:揭示新的诊断标志物(综述)。
Mol Med Rep. 2024 Sep;30(3). doi: 10.3892/mmr.2024.13280. Epub 2024 Jul 4.
6
Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.琥珀酸和腺苷核苷酸代谢途径与 2 型糖尿病患者糖尿病肾病的关系。
Diabetes Metab J. 2024 Nov;48(6):1126-1134. doi: 10.4093/dmj.2023.0377. Epub 2024 Jul 1.
7
Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.探讨过敏性紫癜肾炎的潜在预测因子:尿液代谢物的初步研究。
Eur J Pediatr. 2024 Jul;183(7):3117-3128. doi: 10.1007/s00431-024-05573-9. Epub 2024 Apr 26.
8
Screening candidate diagnostic biomarkers for diabetic kidney disease.筛选糖尿病肾病的候选诊断生物标志物。
J Clin Lab Anal. 2024 Feb;38(3):e25000. doi: 10.1002/jcla.25000. Epub 2024 Feb 1.
9
CKD Urine Metabolomics: Modern Concepts and Approaches.慢性肾脏病尿液代谢组学:现代概念与方法
Pathophysiology. 2023 Sep 29;30(4):443-466. doi: 10.3390/pathophysiology30040033.
10
Metabolic Differences in Diabetic Kidney Disease Patients with Normoalbuminuria versus Moderately Increased Albuminuria.糖尿病肾病患者中正常白蛋白尿与中度白蛋白尿患者的代谢差异。
Kidney360. 2023 Oct 1;4(10):1407-1418. doi: 10.34067/KID.0000000000000248. Epub 2023 Aug 24.
2型糖尿病患者中正常白蛋白尿和肾功能损害的患病率
Clin Nephrol. 2019 Aug;92(2):73-80. doi: 10.5414/CN109606.
4
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis.组织学证据表明糖尿病肾病的临床诊断之前就已经存在。
Am J Nephrol. 2019;50(1):29-36. doi: 10.1159/000500353. Epub 2019 Jun 5.
5
5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.5-羟己酸预测伴有微量白蛋白尿的 2 型糖尿病患者的早期肾功能下降。
Kidney Blood Press Res. 2019;44(2):245-263. doi: 10.1159/000498962. Epub 2019 May 9.
6
Untargeted gas chromatography-mass spectrometry-based metabolomics analysis of kidney and liver tissue from the Lewis Polycystic Kidney rat.基于非靶向气相色谱-质谱联用代谢组学分析的 Lewis 多囊肾病大鼠肾肝组织。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jun 15;1118-1119:25-32. doi: 10.1016/j.jchromb.2019.04.021. Epub 2019 Apr 12.
7
l-Proline Alleviates Kidney Injury Caused by AFB1 and AFM1 through Regulating Excessive Apoptosis of Kidney Cells.脯氨酸通过调节肾细胞过度凋亡缓解 AFB1 和 AFM1 引起的肾损伤。
Toxins (Basel). 2019 Apr 16;11(4):226. doi: 10.3390/toxins11040226.
8
Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.非蛋白尿型与蛋白尿型糖尿病肾病:一项基于全国性、基于活检队列研究的倾向评分匹配分析。
Diabetes Care. 2019 May;42(5):891-902. doi: 10.2337/dc18-1320. Epub 2019 Mar 4.
9
Urine metabolites are associated with glomerular lesions in type 2 diabetes.尿液代谢物与 2 型糖尿病肾小球病变有关。
Metabolomics. 2018 Jun 8;14(6):84. doi: 10.1007/s11306-018-1380-6.
10
11. Microvascular Complications and Foot Care: .11. 微血管并发症与足部护理: 。
Diabetes Care. 2019 Jan;42(Suppl 1):S124-S138. doi: 10.2337/dc19-S011.